TRC-DS is a community of clinical trial volunteers who could help find a cure for Alzheimer's disease for people with Down syndrome.
TRC-DS is part of a larger movement working with people with Down syndrome to advance Alzheimer's disease therapies and potential cures for this population. The Alzheimer's Clinical Trials Consortium-Down Syndrome (ACTC-DS) is a large collaboration of researchers conducting clinical trials for Alzheimer's disease in people with Down syndrome. The University of Colorado has partnered with the ACTC-DS to participate on the Anschutz Medical Campus. TRC-DS is the first of these studies and has the goal of creating a group of eligible volunteers with Down syndrome who are interested in participating in future clinical trials.
Are healthy adults, between ages 35-55, with Down syndrome; Have an interest in participating in clinical research; Will visit the University of Colorado Linda Crnic Institute once every 16 months for routine exams and brain scans.
Principal Investigator